Phenols in pharmaceuticals: analysis of a recurring motif

KA Scott, PB Cox, JT Njardarson - Journal of Medicinal Chemistry, 2022 - ACS Publications
Phenols and phenolic ethers are significant scaffolds recurring both in nature and among
approved small-molecule pharmaceuticals. This compendium presents the first …

Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use

A Skrzypczak-Wiercioch, K Sałat - Molecules, 2022 - mdpi.com
Despite advances in antimicrobial and anti-inflammatory therapies, inflammation and its
consequences still remain a significant problem in medicine. Acute inflammatory responses …

Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos

M Lu, Q Zhao, KL Poston, EV Sullivan… - Medical image …, 2021 - Elsevier
Parkinson's disease (PD) is a brain disorder that primarily affects motor function, leading to
slow movement, tremor, and stiffness, as well as postural instability and difficulty with …

Pesticides and Parkinson's disease: Current and future perspective

MS Islam, F Azim, H Saju, A Zargaran, M Shirzad… - Journal of Chemical …, 2021 - Elsevier
Inappropriate use of pesticides has globally exposed mankind to a number of health
hazards. Still their production is rising at the rate of 11% annually and, has already …

Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease

A Dong, Y Yang, S Jiang, X Yao, D Qi, C Mao… - Acta Pharmacologica …, 2023 - nature.com
Inflammation is one of the pathogenic processes in Parkinson's disease (PD). Dopamine
receptor agonist pramipexole (PPX) is extensively used for PD treatment in clinics. A number …

Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor

Y Zhuang, B Krumm, H Zhang, XE Zhou, Y Wang… - Cell research, 2021 - nature.com
Dear Editor, Dopamine acts as an essential neurotransmitter whose signaling is conducted
through five G protein-coupled receptors (GPCRs), dopamine D1 to D5 receptors (DRD1 …

A patent review on the current developments of benzoxazoles in drug discovery

XK Wong, KY Yeong - ChemMedChem, 2021 - Wiley Online Library
The benzoxazole moiety is widely found in various natural compounds, which are often
found to be biologically active. Due to its versatile biological properties, benzoxazole has …

Lipid-based nanocarriers for neurological disorders: a review of the state-of-the-art and therapeutic success to date

BA Witika, MS Poka, PH Demana, SK Matafwali… - Pharmaceutics, 2022 - mdpi.com
Neurodegenerative disorders including Alzheimer's, Parkinson's, and dementia are chronic
and advanced diseases that are associated with loss of neurons and other related …

Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease

EV Mitroshina, MO Savyuk, E Ponimaskin… - Frontiers in cell and …, 2021 - frontiersin.org
Hypoxia is one of the most common pathological conditions, which can be induced by
multiple events, including ischemic injury, trauma, inflammation, tumors, etc. The body's …

[HTML][HTML] Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced …

S Ahmed, MM El-Sayed, MA Kandeil… - Saudi Pharmaceutical …, 2022 - Elsevier
Abstract Sodium-glucose co-transporter 2 (SGLT 2) inhibitors are a relatively new
antidiabetic drug with antioxidant and anti-inflammatory properties. Therefore, this study …